Using this cut-off, pnSTINGhigh predicted significantly improved relapse free survival (RFS) (HR = 0.405, 95% CI 0.210–0.778, p = 0.0096) compared to either stromal or whole cell tumor STING expression alone (HR = 0.553, 95% CI 0.29–1.05, p = 0.090; HR = 0.554, 95% CI = 0.291–1.06, p = 0.077 respectively) (Fig. 2a–c, Supplementary Table 2). The gene discussed is STING1; the disease is neoplasm.